New jersey

Index
Globenewswire

Boehringer Ingelheim and Palatin Technologies to Develop Potential First-in-class Melanocortin Receptor Targeted Treatment for Patients with Retinal Diseases

Globenewswire

FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

Globenewswire

Verisk Signs Definitive Agreement to Acquire AccuLynx

Globenewswire

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

Globenewswire

Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate

Globenewswire

Synchronoss Meraih Sertifikasi Kerangka Privasi Data UE-A.S.

Globenewswire

Synchronoss Achieves EU-U.S. Data Privacy Framework Certification

Globenewswire

KLOG Transport Solutions Delivers Cargo Visibility Across Europe Powered by ORBCOMM® Satellite IoT Technology

Globenewswire

Spring Bio Solution Meluncurkan NCE Grid untuk Mendekode Peluang Pengajuan Para IV dan First-to-File

Globenewswire

Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities

Globenewswire

ORBCOMM® Launches CrewView to Enable Smart Containers to Fill the Last Gap in End-to-end Visibility While at Sea

Globenewswire

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Globenewswire

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Globenewswire

Verisk Welcomes Christopher Perry and Sabra Purtill to its Board of Directors

Globenewswire

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Globenewswire

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Globenewswire

Verisk Unveils First-of-Its-Kind SRCC Catastrophe Model for the U.S. to Quantify Political Violence Risks

Globenewswire

Trigyn Technologies Appoints Vikram Chandna as Chief Executive Officer

Globenewswire

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

Globenewswire

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Globenewswire

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

Globenewswire

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Globenewswire

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

Globenewswire

UPDATE -- RAM Photonics Industrial Launches Mass Production of 2D Fiber Arrays for AI and DC

Globenewswire

Verisk Nominates Christopher Perry and Sabra Purtill to the Company’s Board of Directors